论文部分内容阅读
近日,《美国国家科学院学报》(PNAS)在线网络版发表的一项新的体外实验研究结果显示,一些为对抗引致严重急性呼吸系统综合征的冠状病毒(SARS-CoV)S 糖蛋白而产生的抗体竟然能使其病毒更容易地进入细胞内。来自于美国国立卫生研究院(NHI)疫苗研究中心的 Gary Nabel 博士及其同事报道指出,虽然在
Recently, a new in vitro experimental study published in the online edition of the Proceedings of the National Academy of Sciences (PNAS) showed that some were produced against the S glycoprotein of the coronavirus (SARS-CoV) that causes severe acute respiratory syndrome Antibodies actually make it easier for the virus to enter the cell. Dr. Gary Nabel and colleagues from the National Institutes of Health vaccine research center reported that although at